OrSense Ltd.'s NBM-200MP System for Continuous Non-Invasive Hemoglobin and Blood Oximetry Measurements Achieves Superior Performance in Hospital Setting

Published: Oct 19, 2009

NEW ORLEANS--(BUSINESS WIRE)--OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, presented today at the American Association of Anesthesiologists (ASA) annual meeting, in New Orleans. The results from a multi-center study indicate that NBM-200MP, a continuous, non-invasive monitoring system, measures levels of oxygen saturation and hemoglobin accurately and reliably in comparison to accepted methods.

Back to news